The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 06, 2023

Filed:

Jan. 10, 2019
Applicant:

MD Healthcare Inc., Seoul, KR;

Inventor:

Yoon-Keun Kim, Paju-si, KR;

Assignee:

MD HEALTHCARE INC., Seoul, KR;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/74 (2015.01); A61P 9/10 (2006.01); C12Q 1/689 (2018.01); A61P 9/06 (2006.01); A61P 25/16 (2006.01); A61P 35/00 (2006.01); A61K 9/127 (2006.01);
U.S. Cl.
CPC ...
A61K 35/74 (2013.01); A61K 9/127 (2013.01); A61P 9/06 (2018.01); A61P 9/10 (2018.01); A61P 25/16 (2018.01); A61P 35/00 (2018.01); C12Q 1/689 (2013.01);
Abstract

Provided are vesicles derived fromand to uses thereof. It has been experimentally confirmed by the present inventors that the vesicles in the clinical samples of patients with gastric cancer, colorectal cancer, liver cancer, pancreatic cancer, cholangiocarcinoma, ovarian cancer, bladder cancer, lymphoma, myocardial infarction, atrial fibrillation, and Parkinson's disease were significantly reduced in comparison with a normal person and that when vesicles isolated from the strain were administered, the secretion of inflammatory mediators caused by pathogenic vesicles, such as-derived vesicles, was significantly inhibited. The vesicles derived fromaccording to the subject matter are expected to be usefully employed for the purposes of developing a method for diagnosing gastric cancer, colorectal cancer, liver cancer, pancreatic cancer, cholangiocarcinoma, ovarian cancer, bladder cancer, lymphoma, myocardial infarction, atrial fibrillation, and/or Parkinson's disease, and a composition for preventing, alleviating, or treating said diseases.


Find Patent Forward Citations

Kim, Yoon-Keun. (2023). Nanovesicles derived fromand uses thereof (U.S. Patent No. 11666607). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11666607

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…